Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Christopher R Ellis Added: 1 year ago
AF Symposium 2024 – In this interview, Dr Christopher R Ellis (Vanderbilt University Medical Center, US) joins us to discuss the early findings from the EMERGE LAA Post-Approval Study.The study investigated the early postapproval outcomes of the Amulet occluder device within the United States, using data from the Left Atrial Appendage Occlusion Registry.Questions:What is the background of this… View more
Author(s): Blandine Mondésert , Pier D Lambiase , Lluis Mont , et al Start date: Oct 23, 2024
This session covers the latest data on transvenous and subcutaneous ICD devices, focusing on shared decision-making and their practical applications in preventing sudden cardiac death. Moderated by Dr Blandine Mondésert (Montreal Heart Institute and University of Montreal, CA) and Dr Ulrika Birgersdotter-Green (University of California San Diego, US), this webinar delves into the long-term… View more
Author(s): Christophe Leclercq Added: 3 months ago
EHRA 2025 - Outcomes from cardiac resynchronization therapy (CRT) with MultiPoint pacing (MPP) to treat patients who are not responding to standard CRT show that MPP does not improve the conversion rate of non-responders to responders compared to standard CRT; however, a reduction in HF hospitalisation was seen in the group receiving MPP.Prof Christophe Leclercq (Centre Hospitalier Universitaire… View more
Author(s): Gi-Byoung Nam , Min Soo Cho Added: 10 months ago
ESC Congress 2024 — Edoxaban monotherapy significantly improves outcomes in high-risk patients with CAD and atrial fibrillation.Investigators, Dr Gi-Byoung Nam (Ulsan University Hospital, Ulsan, SK) and Dr Min Soo Cho (Asan Medical Center, Seoul, SK) join us to discuss the key findings from the EPIC-CAD trial (NCT03718559).This Korean multi-centre, open-labelled, randomised controlled study… View more
Author(s): Dipak Kotecha Added: 10 months ago
ESC Congress 2024 — Improved patient-level adherence to guideline recommendations on heart rhythm control through healthcare professional education in patients with atrial fibrillation.Investigator, Dr Dipak Kotecha (University of Birmingham, UK) joins us in London to share key findings from the STEEER-AF study (NCT04396418).This prospective, cluster-randomized international study compared two… View more
Added: 4 months ago Source:  Arrhythmia Academy
AUTHOR: David RamseyLeading cardiovascular societies have unveiled an updated appropriate use criteria (AUC) document redefining clinical decision-making for cardiac implantable devices. The practice guideline entitled "ACC/AHA/ASE/HFSA/HRS/SCAI/SCCT/SCMR 2025 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Pacing" was published online… View more
The goal of the CICT Conferences is to promote high quality, patient-centered, clinical and technical decision-making in the field of Interventional Cardiovascular Medicine. The uniqueness of the CICT conferences lies in the open forum transparent discussion of controversial topics allowing free flowing interaction between audience and faculty. The content of these meetings addresses a wide range… View more
Research Area(s) / Expertise: Job title: Director of Electrophysiology
An industry leader in complex Electrophysiology cases and research, Dr DeLurgio uses the most advanced technology to detect, diagnose and treat arrhythmias. While some patients can be treated through the use of medication or even pacemakers, Dr DeLurgio also offers treatment through a procedure called a cardiac ablation. During this safe, minimally invasive procedure, Dr DeLurgio uses high tech… View more